Lineage Cell Therapeutics, Inc. Common Stock · Capital Lease Obligations

Latest reported$2.42Mperiod endingDec 31, 2025

LCTX FY Capital Lease Obligations ($0.00 → $2.42M)

Annual capital lease obligations

High-resolution chart · PNG

LCTX capital lease obligations history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Capital Lease Obligations — Annual fiscal periods (USD)
Period ending	Capital Lease Obligations (USD)
Dec 31, 2025	2,419,000
Dec 31, 2024	2,514,000
Dec 31, 2023	2,952,000
Dec 31, 2022	3,896,000
Dec 31, 2021	2,802,000
Dec 31, 2020	3,302,000
Dec 31, 2019	3,945,000
Dec 31, 2018	2,195,000
Dec 31, 2017	1,363,000
Dec 31, 2016	1,898,000
Dec 31, 2015	4,464,000
Dec 31, 2014	467,000
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	0
Jun 30, 1994	0
Jun 30, 1993	0
Jun 30, 1992	0